pamidronate has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate was well tolerated and only grade 1 or 2 toxicities were registered." | 1.35 | Routine use of pamidronate in NSCLC patients with bone metastasis: results from a retrospective analysis. ( Mitterer, M; Seeber, A; Spizzo, G, 2009) |
| "Pamidronate appears to be an effective therapy for HPOA." | 1.30 | The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA). ( Francis, H; Nicklason, F; Speden, D; Ward, J, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, CY | 1 |
| Wang, L | 1 |
| Feng, CJ | 1 |
| Yu, P | 1 |
| Cai, XH | 1 |
| Yao, WX | 1 |
| Xu, Y | 1 |
| Liu, XK | 1 |
| Zhu, WJ | 1 |
| Wang, Y | 1 |
| Zhou, J | 1 |
| Lu, Y | 1 |
| Wang, YS | 1 |
| Spizzo, G | 1 |
| Seeber, A | 1 |
| Mitterer, M | 1 |
| Saba, N | 1 |
| Khuri, F | 1 |
| Andritzky, B | 1 |
| Schuch, G | 1 |
| Thoem, I | 1 |
| Goern, M | 1 |
| Brandl, S | 1 |
| Bokemeyer, C | 1 |
| Laack, E | 1 |
| Speden, D | 1 |
| Nicklason, F | 1 |
| Francis, H | 1 |
| Ward, J | 1 |
1 review available for pamidronate and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; | 2005 |
4 other studies available for pamidronate and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Bisphosphonates enhance EGFR-TKIs efficacy in advanced NSCLC patients with EGFR activating mutation: A retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carc | 2016 |
Routine use of pamidronate in NSCLC patients with bone metastasis: results from a retrospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Ad | 2009 |
Long-term survival after second-line therapy with docetaxel and carboplatin and monthly pamidronic acid in a woman with metastatic non-small cell lung cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; | 2006 |
The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA).
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Diphosphonates; Fatal Outcome; Female; Humans; | 1997 |